Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease

A Caveat in Identifying a Suitable Reference for Quantitative Susceptibility Mapping in Parkinson’s Disease

Study design and methodology of the PREVAIL trial: a phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of subcutaneous ALXN1720 in adults with generalized myasthenia gravis